APO LXR 750 Pill: white, capsule/oblong, 19mm
The pill with imprint APO LXR 750 (White, Capsule/Oblong, 19mm) has been identified as Levetiracetam Extended Release 750 mg and is used for Seizures, and Epilepsy. It belongs to the drug class pyrrolidine anticonvulsants and is not a controlled substance.
Images for APO LXR 750
Levetiracetam Extended Release
- Imprint
- APO LXR 750
- Strength
- 750 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Pyrrolidine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp.
- Inactive Ingredients
-
hypromellose 2208 (15000 mPa.s),
silicon dioxide,
hypromellose 2910 (5 mPa.s),
hydroxypropyl cellulose,
polyethylene glycol 8000,
titanium dioxide,
water
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 60505-3517 | Apotex Corp. |
| 60429-0350 | Golden State Medical Supply (repackager) |
See also:
More about levetiracetam
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (433)
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: pyrrolidine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Levetiracetam oral/injection drug information
- Levetiracetam Extended-Release Tablets
- Levetiracetam Tablets
- Levetiracetam Injection
- Levetiracetam Oral Solution
Other brands
Keppra, Keppra XR, Spritam, Elepsia XR, ... +2 more
Professional resources
- Levetiracetam monograph
- Levetiracetam (FDA)
- Levetiracetam Extended Release Tablets (FDA)
- Levetiracetam Injection (FDA)
- Levetiracetam Injection, Concentrate (FDA)
- Levetiracetam Solution (FDA)
Other brands
Keppra, Keppra XR, Spritam, Elepsia XR, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.